The Goldman Sachs Group Raises Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $33.00
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its target price hoisted by The Goldman Sachs Group from $30.00 to $33.00 in a report released on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities research analysts have also recently weighed in on SNDX. Citigroup lifted their price […]
More Stories
Activest Wealth Management Boosts Stock Holdings in Super Micro Computer, Inc. (NASDAQ:SMCI)
Activest Wealth Management raised its stake in shares of Super Micro Computer, Inc. (NASDAQ:SMCI – Free Report) by 78.9% in...
Activest Wealth Management Acquires 215 Shares of Simon Property Group, Inc. (NYSE:SPG)
Activest Wealth Management raised its holdings in shares of Simon Property Group, Inc. (NYSE:SPG – Free Report) by 20.0% in...
Banco Santander, S.A. (NYSE:SAN) Shares Sold by Activest Wealth Management
Activest Wealth Management cut its stake in Banco Santander, S.A. (NYSE:SAN – Free Report) by 24.8% in the third quarter,...
PGIM High Yield Bond Fund, Inc. (NYSE:ISD) Shares Bought by Activest Wealth Management
Activest Wealth Management increased its stake in shares of PGIM High Yield Bond Fund, Inc. (NYSE:ISD – Free Report) by...
Activest Wealth Management Decreases Position in Capricor Therapeutics Inc (NASDAQ:CAPR)
Activest Wealth Management trimmed its holdings in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) by 50.0% in the...
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Position in Ecolab Inc. (NYSE:ECL)
BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in shares of Ecolab Inc. (NYSE:ECL – Free Report) by 25.3%...